Mrv1533007151510182D 21 23 0 0 0 0 999 V2000 5.7157 2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7144 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7144 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0012 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0012 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.8250 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 1.4289 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 0.8250 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 4 3 2 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 8 7 2 0 0 0 0 11 9 1 0 0 0 0 12 10 1 0 0 0 0 14 1 1 0 0 0 0 14 7 1 0 0 0 0 14 13 2 0 0 0 0 15 2 1 0 0 0 0 15 13 1 0 0 0 0 16 5 2 0 0 0 0 17 8 1 0 0 0 0 17 15 2 0 0 0 0 18 6 2 0 0 0 0 18 16 1 0 0 0 0 19 9 1 0 0 0 0 19 10 1 0 0 0 0 20 11 1 0 0 0 0 20 12 1 0 0 0 0 20 16 1 0 0 0 0 21 17 1 0 0 0 0 21 18 1 0 0 0 0 M CHG 1 19 1 M END > DBMET01391 > drugbank > CC1=CC(C)=C(SC2=CC=CC=C2N2CC[NH2+]CC2)C=C1 > InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3/p+1 > YQNWZWMKLDQSAC-UHFFFAOYSA-O > C18H23N2S > 299.46 > 299.157646343 > 1 > 44 > 35.276707977163596 > 1 > 1 > 1 > 1 > 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium > 1.62 > 4.7609535586666665 > -6.68 > 0 > 3 > 1 > 8.84631496768157 > 19.85 > 105.42339999999999 > 3 > 1 > 7.00e-05 g/l > 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium > 1 > DBMET01391 > Vortioxetine Metabolite 2 $$$$